Adenovirus-Mediated Small Interfering RNA Targeting TAK1 Ameliorates Joint Inflammation with Collagen-Induced Arthritis in Mice
Authors:
- 21 February 2017
- journal article
- research article
- Published by Springer Nature in Inflammation
- Vol. 40 (3) , 894-903
Abstract
Transforming growth factor β-activated kinase-1 (TAK1) is a key upstream kinase in cell signaling during inflammation, which regulates the expression of inflammatory mediators. Small interfering RNA (siRNA) against TAK1 offers promise as a potential therapeutic strategy in immune-mediated inflammatory disorder including rheumatoid arthritis. Here, we are to evaluate the therapeutic effects of intra-articular administration of adenoviral-mediated siRNA against TAK1 (ad-siRNA-TAK1) on collagen-induced arthritis (CIA) in mice. Ad-siRNA-TAK1 was constructed. The murine RAW 264.7 macrophages were infected with ad-siRNA-TAK1, and the silencing specificity of TAK1 was assessed by quantitative polymerase chain reaction (PCR) and western blot. DBA/1 mice were injected intra-articularly with ad-siRNA-TAK1. Development and severity of arthritis was assessed histologically. Synovial inflammation and bone destruction were determined by hematoxylin and eosin (HE) staining. Articular and serum concentrations of tumor necrosis factor-α, interleukin-1, and interleukin-6 were determined using enzyme-linked immunosorbent assay. Levels of phosphorylated p38, c-Jun N-terminal kinase (JNK), and extracellular-signal-regulated kinase (ERK) were detected by western blot. In vitro, ad--siRNA-TAK1 efficiently inhibited the expression of TAK1 at both mRNA and protein levels. In vivo, intra-articular injection of ad-siRNA-TAK1 efficiently alleviated joint inflammation, decreased the expression of pro-inflammatory mediators, and suppressed JNK pathways. Our results demonstrate the efficiency of ad--siRNA-TAK1 in controlling joint inflammation of CIA, which is associated with the suppression of the expression of pro-inflammatory cytokines and JNK activation.Keywords
Funding Information
- National Natural Science Foundation of China (CN) (81373139)
- Zhejiang Provincial Medical Scientific Research Foundation (2015KYA206)
- Zhejiang Provincial Natural Science Foundation of China (LY16H100001)
- Zhejiang Provincial Public Welfare Technology Application Research Project (2015C37122)
This publication has 40 references indexed in Scilit:
- Myeloid Takl Acts as a Negative Regulator of the LPS Response and Mediates Resistance to EndotoxemiaPLOS ONE, 2012
- TAK1 Inhibition Promotes Apoptosis in KRAS-Dependent Colon CancersCell, 2012
- Transforming growth factor beta-activated kinase 1 (TAK1)-dependent checkpoint in the survival of dendritic cells promotes immune homeostasis and functionProceedings of the National Academy of Sciences, 2012
- Interaction between TAK1–TAB1–TAB2 and RCAN1–calcineurin defines a signalling nodal control pointNature Cell Biology, 2009
- TAK1-binding Protein 1, TAB1, Mediates Osmotic Stress-induced TAK1 Activation but Is Dispensable for TAK1-mediated Cytokine SignalingJournal of Biological Chemistry, 2008
- Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritisJournal of Clinical Investigation, 2008
- Regulation of the JNK pathway by TGF-beta activated kinase 1 in rheumatoid arthritis synoviocytesArthritis Research & Therapy, 2007
- Cytokines in the pathogenesis of rheumatoid arthritisNature Reviews Immunology, 2007
- Electro-transfer of small interfering RNA ameliorated arthritis in ratsBiochemical and Biophysical Research Communications, 2005
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001